R. Dienstmann
Universitat de Vic - Universitat Central de Catalunya(ES)Vall d'Hebron Institute of Oncology(ES)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Glioma Diagnosis and Treatment, Genetic factors in colorectal cancer, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group(2024)284 cited
- → Corrigendum to “Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group”(2025)2 cited
- → 290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)(2022)1 cited
- → 686P Next generation sequencing (NGS) helps predict response to immunotherapy (IO) in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)(2022)
- → Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain(2026)
- → Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients(2025)
- → 327P ClinicalTrialsMatch: An AI-assisted process for molecularly-driven patient-trial matching in oncology(2025)
- → 333P A novel target discovery platform: Uncovering targets linked to long-term cancer survival(2025)
- → 125P Circulating tumour DNA (ctDNA) as a prognostic biomarker in patients (pts) with refractory metastatic colorectal cancer (mCRC) receiving TAS102 with or without bevacizumab(2024)
- → 695P Molecular landscape of IDH1/2-mutant gliomas: A Spanish multicentric cohort(2025)